Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats

Interest in the potential therapeutic efficacy of psilocybin and other psychedelic compounds has escalated significantly in recent years. To date, little is known regarding the biological activity of the psilocybin pathway intermediate, norbaeocystin, due to limitations around sourcing the phosphory...

Full description

Bibliographic Details
Main Authors: Alexandra M. Adams, Nicholas A. Anas, Abhishek K. Sen, Jordan D. Hinegardner-Hendricks, Philip J. O’Dell, William J. Gibbons, Jr., Jessica E. Flower, Matthew S. McMurray, J. Andrew Jones
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Metabolic Engineering Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214030122000050